Sleep Quality and Urinary Incontinence in Prostate Cancer Patients: A Data Analytics Approach with the ASCAPE Dataset.

artificial intelligence prostate cancer quality of life sleep quality urinary incontinence

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
11 Sep 2024
Historique:
received: 15 08 2024
revised: 07 09 2024
accepted: 09 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

The ASCAPE project aims to improve the health-related quality of life of cancer patients using artificial intelligence (AI)-driven solutions. The current study employs a comprehensive dataset to evaluate sleep and urinary incontinence, thus enabling the development of personalized interventions. This study focuses on prostate cancer patients eligible for curative treatment with surgery. Forty-two participants were enrolled following their diagnosis and were followed up at baseline and 3, 6, 9, and 12 months after surgical treatment. The data collection process involved a combination of standardized questionnaires and wearable devices, providing a holistic view of patients' QoL and health outcomes. The dataset is systematically organized and stored in a centralized database, with advanced statistical and AI techniques being employed to reveal correlations, patterns, and predictive markers that can ultimately lead to implementing personalized intervention strategies, ultimately enhancing patient QoL outcomes. The correlation analysis between sleep quality and urinary symptoms post-surgery revealed a moderate positive correlation between baseline insomnia and baseline urinary symptoms (r = 0.407, The investigation of sleep quality and urinary incontinence via data analysis through the ASCAPE project suggests that better sleep quality could improve urinary disorders.

Sections du résumé

BACKGROUND BACKGROUND
The ASCAPE project aims to improve the health-related quality of life of cancer patients using artificial intelligence (AI)-driven solutions. The current study employs a comprehensive dataset to evaluate sleep and urinary incontinence, thus enabling the development of personalized interventions.
METHODS METHODS
This study focuses on prostate cancer patients eligible for curative treatment with surgery. Forty-two participants were enrolled following their diagnosis and were followed up at baseline and 3, 6, 9, and 12 months after surgical treatment. The data collection process involved a combination of standardized questionnaires and wearable devices, providing a holistic view of patients' QoL and health outcomes. The dataset is systematically organized and stored in a centralized database, with advanced statistical and AI techniques being employed to reveal correlations, patterns, and predictive markers that can ultimately lead to implementing personalized intervention strategies, ultimately enhancing patient QoL outcomes.
RESULTS RESULTS
The correlation analysis between sleep quality and urinary symptoms post-surgery revealed a moderate positive correlation between baseline insomnia and baseline urinary symptoms (r = 0.407,
CONCLUSIONS CONCLUSIONS
The investigation of sleep quality and urinary incontinence via data analysis through the ASCAPE project suggests that better sleep quality could improve urinary disorders.

Identifiants

pubmed: 39337158
pii: healthcare12181817
doi: 10.3390/healthcare12181817
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Horizon 2020 research and innovation programme
ID : 875351

Auteurs

Ioannis Manolitsis (I)

Second Department of Urology, Sismanoglio General Hospital, National and Kapodistrian University of Athens, 15126 Athens, Greece.

Georgios Feretzakis (G)

School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.

Lazaros Tzelves (L)

Second Department of Urology, Sismanoglio General Hospital, National and Kapodistrian University of Athens, 15126 Athens, Greece.

Athanasios Anastasiou (A)

Biomedical Engineering Laboratory, National Technical University of Athens, 15780 Athens, Greece.

Yiannis Koumpouros (Y)

Digital Innovation in Public Health Research Laboratory, Department of Public and Community Health, University of West Attica, 11521 Athens, Greece.

Vassilios S Verykios (VS)

School of Science and Technology, Hellenic Open University, 26335 Patras, Greece.

Stamatios Katsimperis (S)

Second Department of Urology, Sismanoglio General Hospital, National and Kapodistrian University of Athens, 15126 Athens, Greece.

Themistoklis Bellos (T)

Second Department of Urology, Sismanoglio General Hospital, National and Kapodistrian University of Athens, 15126 Athens, Greece.

Lazaros Lazarou (L)

Second Department of Urology, Sismanoglio General Hospital, National and Kapodistrian University of Athens, 15126 Athens, Greece.

Ioannis Varkarakis (I)

Second Department of Urology, Sismanoglio General Hospital, National and Kapodistrian University of Athens, 15126 Athens, Greece.

Classifications MeSH